What is a clinical trial? A clinical trial is a study that compares the best available standard of care with a new treatment that might be more effective or even safer. If a clinical trial proves that a new treatment is more effective than current therapies, then it may become the new standard of care. It is through clinical trials that we make progress in the battle against cancer and that patients receive 'cutting edge' therapy. Johns Hopkins provides these clinical trial websites as a tool. We have no control over the non-Hopkins sites and do not vouch for their accuracy.
Breast Cancer & Breast Pathology
Breast Cancer Immunotherapy - Cancer Research Institute (CRI)
Find information about studies offered at the Johns Hokins Kimmel Cancer Center by using the search functions below. Search by selecting an adult or pediatric cancer type or you may type in the Johns Hopkins clinical trial research study protocol number. Click "go" to begin your search. A list of clinical trials will appear. Click the reference number above the trial name for specific details about each trial, which may include:. At the Kimmel Cancer Center, our experts recognize that cancer is a complex disease, and each patient is unique. To ensure that every patient receives treatment recommendations that are tailored precisely to his or her cancer, we request that those who are interested in one of our clinical trials, and who are not already a patient at the Kimmel Cancer Center, schedule a new patient consultation.
Sidney Kimmel Comprehensive Cancer Center
What is a clinical trial? A clinical trial is a study that compares the best available standard of care with a new treatment that might be more effective or even safer. If a clinical trial proves that a new treatment is more effective than current therapies, then it may become the new standard of care.
Study record managers: refer to the Data Element Definitions if submitting registration or results information. This research is being done to learn more about the side effects of breast cancer hormone therapy and if a person's genetic information may help us to develop a way to predict the side effects a patient may have and how best to treat them. In addition, the investigators hope to look at how the side effects from hormone therapy influence a patient's willingness to continue hormonal treatment. Men and women being prescribed hormone therapies including Tamoxifen, Raloxifene Evista , Anastrozole Arimidex , Letrozole Femara , or Exemestane Aromasin , by their oncologist for either prevention of breast cancer or treatment of breast cancer may join. The decision of which hormone therapy to receive is the decision of the patient and physician, this study will collect samples and patient-reported outcomes during this routine, standard of care and will not direct any treatment decisions or interventions in any way.